Stay updated on Denosumab & Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Denosumab & Pembrolizumab in RCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed older maintenance notices (including Revision: v3.4.1) as part of minor site upkeep. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding lapse notice appears on the page with operating-status guidance, and the site revision is updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedMinor UI and metadata updates: Show glossary option added, label capitalizations adjusted (Last Update Submitted that Met QC Criteria; No FEAR Act Data), and a new footer note 'Revision: v3.4.0' replacing the previous version.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous revision v3.3.3.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations section updated to include New South Wales, Queensland, South Australia, Victoria, and Western Australia, and individual state location pages were removed.SummaryDifference0.6%

- Check92 days agoChange DetectedRevision: v3.3.2 released, replacing the previous v3.2.0. The update does not modify the study details or page content.SummaryDifference0.0%

Stay in the know with updates to Denosumab & Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.